Wall Street analysts have been busy tweaking their assessments of several major companies, with notable changes in ratings and price targets. Here’s a breakdown of the recent adjustments:
Blackstone Inc. (BX):
Piper Sandler analyst Crispin Love has downgraded the rating for Blackstone from Overweight to Neutral, while maintaining a price target of $149. This shift in sentiment comes as Blackstone shares closed at $49.44 on Tuesday.
Virpax Pharmaceuticals, Inc. (VRPX):
Maxim Group analyst Naz Rahman has downgraded the rating for Virpax Pharmaceuticals from Buy to Hold. Virpax shares ended the day at $0.4810 on Tuesday.
Daqo New Energy Corp. (DQ):
Daiwa Capital analyst Dennis Ip has downgraded Daqo New Energy from Outperform to Hold, but with a twist – he also raised the price target from $18 to $25. Daqo New Energy settled at $20.94 on Tuesday.
FactSet Research Systems Inc. (FDS):
Redburn Atlantic analyst Russell Quelch has downgraded the rating for FactSet Research Systems from Neutral to Sell, alongside a lowered price target from $420 to $380. FactSet shares closed at $456.83 on Tuesday.These rating changes provide valuable insights into the current market dynamics and how analysts are interpreting the performance of these companies. Investors can use this information to make informed decisions about their portfolios. Remember, these are just analyst opinions and should be considered alongside your own research and investment goals.
